HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy - PubMed (original) (raw)
HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy
Andy I Choi et al. AIDS. 2009.
Abstract
Objective: To identify risk factors associated with kidney function decline in a contemporary cohort of treated and untreated HIV-infected patients.
Methods: We followed individuals enrolled in the Study of the Consequences Of the Protease inhibitor Era cohort for longitudinal changes in kidney function, defined as glomerular filtration rate estimated from serum creatinine (eGFR). eGFR slope was calculated using linear mixed effects models adjusted for age, sex, race, and time-updated CD4 cell count, viral load, antiretroviral therapy (ART), and comorbid conditions.
Results: We followed 615 patients for a mean of 3.4 (+/- 2.5) years. In multivariable adjusted analyses, predictors of eGFR decline included female sex, diabetes, and hyperlipidemia; CD4 cell count and viral load were not associated with eGFR loss. Among patients who initiated treatment, antiretroviral exposure was associated with a +2.8 (95% confidence interval 0.8-4.7) ml/min per 1.73 m per year effect on eGFR slope. Although these patients appeared to benefit from ART based on the slowing of their eGFR decline, they continued to lose kidney function at a rate of -1.9 (95% confidence interval -3.7 to -0.1) ml/min per 1.73 m per year. In the subgroup of individuals receiving suppressive ART with viral loads maintained below 500 copies/ml, intermittent viremic episodes (blips) were strongly associated with more rapid rates of eGFR loss [-6.7 (95% confidence interval -11.1 to -2.4) ml/min per 1.73 m per year].
Conclusion: Although ART appears to help curb kidney function decline, patients who achieved durable viral suppression continue to manifest substantial loss of eGFR. Loss of kidney function may be attributable to treatment-related factors, intermittent viremia, and traditional risk factors for kidney disease.
References
- Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005;40:1559–1585. - PubMed
- Szczech LA, Gange SJ, van der Horst C, Bartlett JA, Young M, Cohen MH, et al. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 2002;61:195–202. - PubMed
- Choi AI, Rodriguez RA, Bacchetti P, Volberding PA, Havlir D, Bertenthal D, et al. Lowrates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. Clin Infect Dis. 2007;45:1633–1639. - PubMed
- Gardner LI, Klein RS, Szczech LA, Phelps RM, Tashima K, Rompalo AM, et al. Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women. J Acquir Immune Defic Syndr. 2003;34:320–330. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K23 DK080645/DK/NIDDK NIH HHS/United States
- MH59037/MH/NIMH NIH HHS/United States
- K24AI069994/AI/NIAID NIH HHS/United States
- K24 AI069994/AI/NIAID NIH HHS/United States
- K23DK080645-01A1/DK/NIDDK NIH HHS/United States
- R01 DK066488/DK/NIDDK NIH HHS/United States
- UL1RR024131-01/RR/NCRR NIH HHS/United States
- P30 AI027763/AI/NIAID NIH HHS/United States
- R01 DK066488-01/DK/NIDDK NIH HHS/United States
- AI27763/AI/NIAID NIH HHS/United States
- K23AI65244/AI/NIAID NIH HHS/United States
- K23 DK080645-02/DK/NIDDK NIH HHS/United States
- KL2 RR024130/RR/NCRR NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- K23 AI065244/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous